Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 229-846-0 | CAS number: 6784-13-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Between 21 April 2005 and 25 May 2005
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 005
- Report date:
- 2005
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
- Limit test:
- no
Test material
- Reference substance name:
- β,4-dimethylcyclohex-3-ene-1-propan-1-al
- EC Number:
- 229-846-0
- EC Name:
- β,4-dimethylcyclohex-3-ene-1-propan-1-al
- Cas Number:
- 6784-13-0
- Molecular formula:
- C11H18O
- IUPAC Name:
- 3-(4-methylcyclohex-3-en-1-yl)butanal
- Test material form:
- liquid
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River (UK) Ltd, Margate, Kent, UK
- Females (if applicable) nulliparous and non-pregnant: yes
- Age at study initiation: 8-12 weeks
- Fasting period before study: The rats were fasted overnight prior to dosing, with food being returned to the rats approximately 3-4 hours after the first dose
- Housing: The animals were housed in groups of three in suspended solid-floor polypropylene cages furnished with woodflakes
- Diet:ad libitum except during fasting
- Water: water ad libitum except during fasting
- Acclimation period: 5 days
- Microbiological status when known: The animals were provided with environmental enrichment items which were considered not to contain any contaminant of a level that might have affected the purpose or integrity of the study.
ENVIRONMENTAL CONDITIONS
- Temperature: 19-25ºC
- Humidity: 30-70%
- Air changes: The rate of air exchange was at least fifteen changes per hour and the lighting was controlled by a time switch to give twelve hours continuous light (06:00 to 18:00) and twelve hours darkness.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: The test material was administered orally undiluted for the 2000 mg/kg dose level and orally as a solution in arachis oil BP for the 300 mg/kg dose level.
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 30 mg/mL for 300 mg/kg
- Justification for choice of vehicle: Arachis oil BP was used because the test material did not dissolve/suspend in distilled water
MAXIMUM DOSE VOLUME APPLIED: 2.14 mL/kg for 2000 mg/kg; 10 mL/kg go 2000 mg/kg
CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: Using all available information on the toxicity of the test material, 2000 mg/kg was chosen as the starting dose. - Doses:
- 300 mg/kg bw and 2000 mg/kg bw.
- No. of animals per sex per dose:
- 6 females per dose
- Control animals:
- no
- Details on study design:
- The animals were observed for deaths or overt signs of toxicity 1/2, 1, 2 and 4 hours after dosing and subsequently once daily for up to fourteen days. Due to a technical error the observations of three animals treated at a dose level of 300 mg/kg on Day 2 were not performed. This was considered not to affect the purpose or integrity of the study.
Individual bodyweights were recorded prior to dosing and seven and fourteen days after treatment or at death. At the end of the observation period the surviving animals were killed by cervical dislocation. All animals were subjected to gross pathological examination. This consisted of an external examination and opening of the abdominal and thoracic cavities for examination of major organs. The appearance of any macroscopic abnormalities was recorded. No tissues were retained.
Results and discussion
Effect levels
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- One animal treated at a dose level of 2000 mg/kg was killed in extremis and one other animal at
this dose level was found dead one day after dosing. There were no deaths noted in animals treated at a dose level of 300 mg/kg. - Clinical signs:
- other:
- Body weight:
- other body weight observations
- Remarks:
- The surviving animals showed expected gains in bodyweight over the study period.
- Gross pathology:
- Abnormalities noted at necropsy of the animal that died during the study were abnormally red lungs, dark liver and dark kidneys. No abnormalities were noted at necropsy of animals that were killed in extremis or at the end of the study.
Applicant's summary and conclusion
- Interpretation of results:
- other: not acute harmful according to EU CLP (EC 1272/2008 and its amendments)
- Conclusions:
- The acute oral median lethal dose (LD50) of the test material in the female Sprague-Dawley CD strain rat was >2000 mg/kg bw
- Executive summary:
The study was conducted to assess the acute oral toxicity of limoxal in accordance with the OECD Guideline 423 in compliance with GLP.
A group of three fasted females was treated with the test material at a dose level of 2000 mg/kg bw. This was followed by a further group of three fasted females at the same dose level. Based on the results from this dose level a further two groups of fasted females were treated at a dose level of 300 mg/kg bw. Dosing was performed sequentially. The test material was administered orally undiluted for the 2000 mg/kg dose level and orally as a solution in arachis oil BP for the 300 mg/kg dose level. Clinical signs and bodyweight development were monitored during the study. All animals were subjected to gross necropsy.
At 2000 mg/kg, one animal was found dead one day after dosing and one animal was killed in extremis at this time. Signs of systemic toxicity noted in animals treated at a dose level of 2000 mg/kg were hunched posture, ataxia, lethargy, pilo-erection, decreased respiratory rate, laboured respiration, loss of righting reflex, occasional body tremors, tiptoe gait and coma. Surviving animals treated at a dose level of 2000 mg/kg appeared normal two, three or six days after dosing. There were no signs of systemic toxicity noted in animals treated at a dose level of 300 mg/kg. The surviving animals showed expected gains in bodyweight over the study period. Abnormalities noted at necropsy of the animal that died during the study were abnormally red lungs, dark liver and dark kidneys. No abnormalities were noted at necropsy of animals that were killed in extremis or at the end of the study.
The acute oral median lethal dose (LD50) of the test material in the female Sprague-Dawley CD strain rat was >2000 mg/kg bw.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.